|Day Low/High||3.88 / 3.99|
|52 Wk Low/High||2.82 / 6.49|
Preliminary results show targeted treatment offers low toxicity for patients with endometrial or cervical cancer
First installation of advanced, multi-platform Xoft System in Australia increases global access to versatile, clinically proven technology
Company to host in-booth presentations by clinical experts to review recent experience with one-day intraoperative radiation therapy
This portfolio is designed to produce a blended yield of 6% to 8%.
Company to showcase breakthrough, multi-platform technology for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers at booth #T1
Latest digital breast 3D tomosynthesis solution builds on deep learning technology to improve radiologist workflow and significantly reduce reading time
First to market with innovative digital breast 3D tomosynthesis cancer detection and workflow solution, built on deep learning technology that improves efficiency and reduces reading time for radiologists
Company to showcase breakthrough one-day breast cancer treatment technology and host in-booth clinician expert at Physicians' Education Resource® 34th Annual Miami Breast Cancer Conference
Company to highlight breakthrough Xoft System offering excellent clinical results and host in-booth Lunch and Learn sessions featuring clinical experts to discuss strategies and outcomes in patient care
iCAD, Inc., (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, today announced that its mammography Computer...